UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Targeting protein-tyrosine phosphatases in breast cancer

Oncotarget, 2012-05, Vol.3 (5), p.514-515

2012

Link zum Volltext

Verfügbarkeit prüfen

Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages

Oncotarget, 2016-12, Vol.7 (50), p.82289-82304

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

Oncotarget, 2015-03, Vol.6 (8), p.6191-6202

2015

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue

Oncotarget, 2017-04, Vol.8 (14), p.22353-22360

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Oncotarget, 2016-05, Vol.7 (19), p.28697-28710

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome

Oncotarget, 2016-04, Vol.7 (16), p.21922-21938

2016

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid metabolism in breast cancer subtypes

Oncotarget, 2017-04, Vol.8 (17), p.29487-29500

Monaco, Marie E

2017

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors

Oncotarget, 2016-02, Vol.7 (8), p.9250-9270

2016

Link zum Volltext

Verfügbarkeit prüfen

Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI

Oncotarget, 2017-07, Vol.8 (28), p.45759-45767

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment

Oncotarget, 2016-08, Vol.7 (31), p.49349-49367

2016

Link zum Volltext

Verfügbarkeit prüfen

CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway

Oncotarget, 2016-03, Vol.7 (13), p.15632-15647

2016

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer

Oncotarget, 2015-06, Vol.6 (17), p.14913-14925

2015

Link zum Volltext

Verfügbarkeit prüfen

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling

Oncotarget, 2015-05, Vol.6 (13), p.11585-11599

2015

Link zum Volltext

Verfügbarkeit prüfen

Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy

Oncotarget, 2017-12, Vol.8 (64), p.107374-107389

2017

Link zum Volltext

Verfügbarkeit prüfen

Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker

Oncotarget, 2017-09, Vol.8 (43), p.75742-75755

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

Oncotarget, 2017-06, Vol.8 (24), p.39230-39240

2017

Link zum Volltext

Verfügbarkeit prüfen

SHP2 phosphatase as a novel therapeutic target for melanoma treatment

Oncotarget, 2016-11, Vol.7 (45), p.73817-73829

2016

Link zum Volltext

Verfügbarkeit prüfen

SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells

Oncotarget, 2017-08, Vol.8 (32), p.53518-53530

2017

Link zum Volltext

Verfügbarkeit prüfen

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer

Oncotarget, 2017-12, Vol.8 (70), p.115270-115279

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients

Oncotarget, 2017-09, Vol.8 (37), p.61538-61550

2017

Link zum Volltext

Verfügbarkeit prüfen

Shp2 regulates migratory behavior and response to EGFR-TKIs through ERK1/2 pathway activation in non-small cell lung cancer cells

Oncotarget, 2017-10, Vol.8 (53), p.91123-91133

2017

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway

Oncotarget, 2017-09, Vol.8 (38), p.63923-63934

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic siRNA for drug-resistant HER2-positive breast cancer

Oncotarget, 2016-03, Vol.7 (12), p.14727-14741

2016

Link zum Volltext

Verfügbarkeit prüfen

Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas

Oncotarget, 2015-10, Vol.6 (32), p.32317-32338

2015

Link zum Volltext

Verfügbarkeit prüfen

Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells

Oncotarget, 2016-11, Vol.7 (44), p.71580-71593

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

ThemaGene Expression Regulation, Neoplastic

Zeitschrift / SerieOncotarget

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Targeting protein-tyrosine phosphatases in breast cancer

Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome

Fatty acid metabolism in breast cancer subtypes

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors

Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI

Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment

CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling

Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy

Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker

Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

SHP2 phosphatase as a novel therapeutic target for melanoma treatment

SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer

Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients

Shp2 regulates migratory behavior and response to EGFR-TKIs through ERK1/2 pathway activation in non-small cell lung cancer cells

Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway

Therapeutic siRNA for drug-resistant HER2-positive breast cancer

Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas

Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells

Aktive Filter

Suchergebnisse filtern